A panel of fusion innovators explore the path to commercialisation, the challenges, and their expectations, across tokamaks & stellarator approaches.

• What challenges remain to surpass break-even in private-sector MCF?
• What is the current state of HTS technology and what is its contribution both as core-tech and as a spin-out?
• What are the key milestones in de-risking MCF fusion approaches and when will they be retired?
• What new technologies and cost pathways are needed to make MCF fusion commercially viable, and how close are they?

Moderated by: Malcolm Handley, Partner & Founder, Strong Atomics